Skip to main content
Access Resources

MJFF Publications

2811 - 2820 of 7540 Results
Title
Year
  • Year
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • RESTRICTED
    Title: Data imputation and compression for Parkinson's disease clinical questionnaires
    Journal Name: Artificial Intelligence in Medicine
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.artmed.2021.102051
    Citation Count: 12
  • RESTRICTED
    Title: Deep mining of oxysterols and cholestenoic acids in human plasma and cerebrospinal fluid: Quantification using isotope dilution mass spectrometry
    Journal Name: Analytica Chimica Acta
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.aca.2021.338259
    Citation Count: 13
  • RESTRICTED
    Title: Disruption of the Atrophy-based Functional Network in Multiple Sclerosis Is Associated with Clinical Disability: Validation of a Meta-Analytic Model in Resting-State Functional MRI
    Journal Name: Radiology
    Publisher: Radiological Society of North America (RSNA)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1148/radiol.2021203414
    Citation Count: 5
  • RESTRICTED
    Title: Distinct neural circuits are associated with subclinical neuropsychiatric symptoms in Parkinson's disease
    Journal Name: Journal of the Neurological Sciences
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.jns.2021.117365
    Citation Count: 13
  • RESTRICTED
    Title: Drug Repurposing: Considerations to Surpass While Re-directing Old Compounds for New Treatments
    Journal Name: Archives of Medical Research
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.arcmed.2020.10.021
    Best OA location URL:
    Citation Count: 22
  • RESTRICTED
    Title: Evaluation of treatment effects in patients with endometrial cancer and POLE mutations: An individual patient data meta‐analysis
    Journal Name: Cancer
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/cncr.33516
    Citation Count: 60
  • RESTRICTED
    Title: Fluoxetine for the Symptomatic Treatment of Multiple System Atrophy: The MSA‐FLUO Trial
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.28569
    Citation Count: 18
  • RESTRICTED
    Title: Genetic updates on paroxysmal dyskinesias
    Journal Name: Journal of Neural Transmission
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/s00702-021-02335-x
    Best OA location URL:
    Citation Count: 5
  • RESTRICTED
    Title: Genome-Wide Association Study Meta-Analysis for Parkinson Disease Motor Subtypes
    Journal Name: Neurology Genetics
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc-nd, cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1212/nxg.0000000000000557
    Citation Count: 24
  • RESTRICTED
    Title: Identification of Candidate Parkinson Disease Genes by Integrating Genome-Wide Association Study, Expression, and Epigenetic Data Sets
    Journal Name: JAMA Neurology
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1001/jamaneurol.2020.5257
    Citation Count: 91
Filters
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.